Articles tagged "Pancreas transplantation"

2020 American Transplant Congress
Experimental Porcine Pancreatic Allotransplantation after Hypothermic Perfusion
T. Prudhomme¹, D. Kervella¹, K. Renaudin², V. Gauttier¹, S. Le Bas-Bernardet³, D. Minault³, J. Hervouet³, D. Cantarovich¹, G. Karam¹, G. Blancho¹, J. Branchereau¹
¹Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France, ²Département d’Anatomie et de Cytologie Pathologique, CHU Nantes, Nantes, France, ³Centre de Recherche en Transplantation et Immunologie, UMR1064, INSERM, Université de Nantes, Nantes, France
*Purpose: The main objective of this study was to compare the different preservation techniques (static cold storage (SCS) and hypothermic pulsatile perfusion (HPP)) in a…
2020 American Transplant Congress
Early Corticosteroid Withdrawal in Pancreas and Simultaneous Pancreas-Kidney Transplant Recipients: Long-Term Clinical and Metabolic Outcomes of from a Single Center Retrospective Cohort
A. Lichvar, L. Lin, Y. Chen, Y. Yen, D. Pierce, A. Nadeem, P. West-Thielke, I. Tang, J. Almario, M. Spaggiari, I. Tzvetanov, E. Benedetti, M. Campara
University of Illinois at Chicago, Chicago, IL
*Purpose: Tacrolimus, mycophenolate mofetil, and chronic corticosteroids (CCS) are the most popular immunosuppression regimen after pancreas transplantation. Early corticosteroid withdrawal (ECSWD) is an increasingly popular…
2020 American Transplant Congress
Impact and Outcomes of Primary Cytomegalovirus Infection in Seronegative Abdominal Solid Organ Transplant Recipients of Cytomegalovirus Unexposed Donors (D-/R-)
M. Jorgenson¹, M. Hillis¹, N. Friedlander¹, A. Gracon², D. Yang², G. Leverson², J. Smith², R. Redfield²
¹UWHC, Madison, WI, ²UWMF, Madison, WI
*Purpose: Primary cytomegalovirus infection (CMV) in high risk (D+/R-) abdominal solid organ transplant recipients (aSOTRs) is well described, however there is a paucity of literature…
2020 American Transplant Congress
Quantifiable Loss of Insulin Secretory Granules in Delayed Endocrine Pancreas Graft Function in Comparison to Controls
C. B. Drachenberg¹, J. C. Papadimitriou¹, J. R. Scalea², A. Haririan³, R. Ugarte³, S. Niederhaus², J. Bromberg²
¹Pathology, University of Maryland, Baltimore, MD, ²Surgery, University of Maryland, Baltimore, MD, ³Medicine, University of Maryland, Baltimore, MD
*Purpose: Approximately 1/3 of pancreas transplant fail to gain glycemic control in the first days/weeks posttransplantation, requiring exogenous insulin administration. Delayed endocrine pancreas graft function…
2020 American Transplant Congress
Implications for Facilitated Pancreas Transplant Allocation with the Removal of Donor Service Area
R. Forbes¹, R. Urban², A. Fox², J. Odorico³, S. Niederhaus⁴
¹Vanderbilt University Medical Center, Nashville, TN, ²United Network for Organ Sharing, Richmond, VA, ³University of Wisconsin, Madison, WI, ⁴University of Maryland, Baltimore, MD
*Purpose: Facilitated Pancreas (FP) Allocation, modified in August 2016 to be metric-based rather than opt-in, defines an eligible center as one that has transplanted at…
2020 American Transplant Congress
Risk Factors for Early Graft Loss and Mortality in Pancreas Transplant Recipients: A Multivariate Analysis of U.S. Transplants
S. M. Riad¹, A. Adamusiak², S. Jackson³, E. B. Finger², R. Kandaswamy²
¹Medicine, University of Minnesota, Minneapolis, MN, ²Surgery, University of Minnesota, Minneapolis, MN, ³Complex Care Analytics, Fairview Health Services, Minneapolis, MN
*Purpose: There is limited data on trends of early graft loss within 90 days (EGL). Pancreas donor risk index (PDRI) is a scale of pancreas…
2020 American Transplant Congress
Beta Cell Replacement Therapy in Nonuremic Patients with Brittle T1DM Allows for Durable Long Term Insulin Independence Halting Progression of Secondary Diabetic Complications
P. J. Bachul¹, D. J. Grybowski¹, R. Anteby², L. Basto¹, L. Perea¹, K. Golab¹, L. Wang¹, M. Tibudan¹, A. Perez-Gutierrez¹, M. Komorniczak³, A. Lucander¹, P. Borek¹, M. Dimitrov¹, J. Fung¹, P. Witkowski¹
¹Surgery, University of Chicago, Chicago, IL, ²Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, ³Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
*Purpose: Beta cell replacement therapy in form of pancreas or islet transplantation is the only effective treatment for patients suffering from hypoglycemic unawareness despite intensive…
2020 American Transplant Congress
Systemic Venous versus Portal Venous Drainage in Simultaneous Pancreas-Kidney Transplantation: A Matched-Pair Analysis
V. Gurram, K. Gurung, A. Farney, J. Rogers, G. Orlando, C. Jay, A. Reeves-Daniel, R. Stratta
Abdominal Transplant Surgery, Wake Forest Baptist Health, Winston Salem, NC
*Purpose: The study purpose was to evaluate outcomes in vascularized pancreas transplantation (PTx) with enteric exocrine drainage based on technique of venous delivery.*Methods: We retrospectively…
2020 American Transplant Congress
Delayed Kidney Graft Function in Simultaneous Pancreas-Kidney Transplant Recipients is Associated with Pancreas Allograft Failure
S. Parajuli, B. Muth, B. C. Astor, R. R. Redfield, D. Mandelbrot, J. Odorico, A. Djamali, D. Kaufman
University of Wisconsin, Madison, WI
*Purpose: Delayed graft function (DGF) is a common complication associated with significant untoward effects in kidney-alone transplantation. The incidence and outcomes following kidney delayed graft…
2019 American Transplant Congress
Outcomes after Simultaneous Kidney Pancreas versus Pancreas after Kidney Transplantation
S. Parajuli, A. Arunachalam, K. Swanson, F. Aziz, N. Garg, R. Redfield, D. Kaufman, A. Djamali, J. Odorico, D. Mandelbrot
University of Wisconsin, Madison, WI
*Purpose: Simultaneous pancreas and kidney (SPK) or pancreas after kidney (PAK) transplant are potential options for diabetic ESRD patients. Historically, PAK pancreas graft outcomes were…

« Previous Page
1
…
7
8
9
10
11
…
28
Next Page »